HealthEquity (NASDAQ:HQY) Stock Price Down 3.1%

HealthEquity, Inc. (NASDAQ:HQY) dropped 3.1% during trading on Wednesday . The company traded as low as $83.06 and last traded at $83.12. Approximately 128,659 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 603,554 shares. The stock had previously closed at $85.76.

Analyst Ratings Changes

HQY has been the topic of a number of research analyst reports. JMP Securities upped their price target on shares of HealthEquity from $101.00 to $105.00 and gave the stock a “market outperform” rating in a report on Tuesday, June 4th. BTIG Research upped their price target on shares of HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, March 20th. KeyCorp upped their price target on shares of HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. Raymond James upped their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. Finally, Wells Fargo & Company upped their price target on shares of HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a report on Thursday, June 20th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $101.67.

HealthEquity Trading Down 2.6 %

The firm has a market capitalization of $7.27 billion, a PE ratio of 90.83, a price-to-earnings-growth ratio of 1.41 and a beta of 0.57. The company’s 50-day simple moving average is $81.43 and its 200 day simple moving average is $78.56. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, June 3rd. The company reported $0.55 EPS for the quarter, beating the consensus estimate of $0.47 by $0.08. The business had revenue of $287.60 million during the quarter, compared to analyst estimates of $278.78 million. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. As a group, sell-side analysts expect that HealthEquity, Inc. will post 2.12 EPS for the current year.

Insider Activity at HealthEquity

In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the firm’s stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the transaction, the chief executive officer now directly owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other HealthEquity news, Vice Chairman Stephen Neeleman sold 400 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $85.00, for a total transaction of $34,000.00. Following the completion of the transaction, the insider now directly owns 90,515 shares of the company’s stock, valued at approximately $7,693,775. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jon Kessler sold 32,326 shares of the firm’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the transaction, the chief executive officer now directly owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The disclosure for this sale can be found here. Insiders sold 34,806 shares of company stock valued at $2,888,383 in the last three months. 2.20% of the stock is owned by insiders.

Institutional Investors Weigh In On HealthEquity

Hedge funds and other institutional investors have recently made changes to their positions in the company. Rise Advisors LLC acquired a new stake in shares of HealthEquity during the 1st quarter worth approximately $28,000. Cape Investment Advisory Inc. acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $27,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $29,000. YHB Investment Advisors Inc. acquired a new stake in shares of HealthEquity during the 1st quarter worth approximately $40,000. Finally, Fidelis Capital Partners LLC acquired a new stake in shares of HealthEquity during the 1st quarter worth approximately $42,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.